| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |